From: Health service providers in Somalia: their readiness to provide malaria case-management
 | Total | ||
---|---|---|---|
 | Hospital/MCH-OP (n = 22) | HP (n = 23) | All (n = 45) |
Reported use of anti-malarials for first-line treatment* | Â | Â | Â |
   AS-SP | 21 (95.5%) | 0 | 21 (46.7%) |
   SP | 0 | 7 (30.4%) | 7 (15.6%) |
   Chloroquine | 1 (4.5%) | 16 (69.6%) | 17 (37.8%) |
Reported use of anti-malarials for second-line treatment** | Â | Â | Â |
   Never use | 1 (4.5%) | 14 (63.6%) | 15 (33.3% |
   Quinine | 20 (91.0%) | 2 (8.7%) | 22 (48.9%) |
   SP | 1 (4.5%) | 7 (30.4%) | 8 (17.8%) |
Nationally recommended first-line therapy in stock on day of survey*** | 12 (54.5%) | 3 (13.0%) | 15 (33.3%) |
Nationally recommended second-line therapy in stock on day of survey | 19 (86.4%) | 0 | 19 (42.2%) |
Parasitological diagnosis**** | Â | Â | Â |
   None | 2 (9.0%) | 23 (100.0%) | 25 (55.5%) |
   RDT | 20 (91.0%) | 0 | 20 (44.4%) |
   Microscopy | 12 (54.5%) | 0 | 12 (26.7%) |
RDT in stock on day of survey | 11 (50.0%) | 0 | 11 (24.4%) |
Revised national guidelines available at facility**** | 14 (63.6%) | 0 | 14 (31.1%) |
RDT use wall charts available at facility**** | 18 (81.8%) | 0 | 18 (40.0%) |
Anti-malarial dosing wall charts available at facility | 18 (81.8%) | 1 (4.3%) | 19 (42.2%) |
Charging for malaria consultation, diagnosis or treatment | 8 (36.4%) | 9 (39.1%) | 17 (37.7%) |